July 24 , 2024
China’s First In Vivo Gene Editing Drug Administered to First ATTR Patient at PUMCH
Recently, Professor Zhang Shuyang, President of PUMCH, and Professor Tian Zhuang administered YOLT-201, China’s first domestically developed gene edit...